<!doctype html>
<html>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Nayan Lab | Madhur Nayan</title> <meta name="author" content="Nayan Lab | Madhur Nayan"/> <meta name="description" content="Nayan Lab, New York University"/> <meta name="keywords" content="urology, ai, machine learning, oncology"/> 
<link href="index.css" rel="stylesheet" type="text/css">

<div class="container">
	
<body>
	<div class="header">
<h1>Nayan Lab | Madhur Nayan, MD.CM., Ph.D.</h1>
	</div>
	
<div id="menu">
	<a href="index.html">Home</a>
	<a class="active" href="publications.html">Publications</a>
	<a href="contact.html">Contact</a>
</div>
	
<h2>Journal Articles</h2>
<ol>
  <li><strong>Nayan M,</strong> Carvalho FLF, Feldman AS. <a href="https://pubmed.ncbi.nlm.nih.gov/35044491/" target="new">Active  surveillance for intermediate risk prostate cancer.</a> World J Urol. 2022  Jan;40(1):79-86. doi: 10.1007/s00345-021-03893-1.</li>
  <li>Carvalho FLF, Wang Y, Dall CP, <strong>Nayan M</strong>,  Chou WH, McGregor B, Sopfkuchen-Evans MF, Stamatakis L, Preston MA, Kibel AS,  Chang SL, Mossanen M. <a href="https://pubmed.ncbi.nlm.nih.gov/35690547/" target="new">Preoperative anemia is associated with increased radical  cystectomy complications.</a> Urol Oncol. 2022 Aug;40(8):382.e7-382.e13. doi:  10.1016/j.urolonc.2022.04.014.</li>
  <li>Cheung DC, Martin LJ, Jivraj NK, Clarke H, Gomes  T, Wijeysundera DN, Diong C, <strong>Nayan M</strong>, Saarela O, Alibhai SMH,  Komisarenko M, Fleshner NE, Kulkarni GS, Finelli A. <a href="https://pubmed.ncbi.nlm.nih.gov/35182588/" target="new">Opioid Use After  Nephrectomy for Kidney Cancer in Ontario: A Population-Based Study.</a> Urology.  2022 Jun;164:118-123. doi: 10.1016/j.urology.2022.02.002.</li>
  <li><strong>Nayan M,</strong> Carvalho FLF, Feldman AS. Active  surveillance for intermediate risk prostate cancer. World J Urol. 2022  Jan;40(1):79-86. doi: 10.1007/s00345-021-03893-1.</li>
  <li><strong>Nayan M</strong>, Hamilton RJ, Juurlink DN, Austin  P, Jarvi KA. Circumcision and risk of HIV among males from Ontario, Canada. J  Urol. 2021 Sep 23;101097JU0000000000002234. doi: 10.1097/JU.0000000000002234.
    <ul>
      <li>Article featured on Yahoo.com <a href="https://www.yahoo.com/now/does-circumcision-actually-help-prevent-001811897.html">https://www.yahoo.com/now/does-circumcision-actually-help-prevent-001811897.html</a></li>
    </ul>
  </li>
  <li><strong>Nayan M</strong>, Salari M, Bozzo A, Ganglberger W,  Carvalho F, Feldman AS, Trinh QD. &ldquo;Predicting survival after radical  prostatectomy: variation of machine learning performance by race&rdquo;. Prostate.  2021 Sep 16. doi: 10.1002/pros.24233.
    <ul>
      <li>Presented at the 2021 Machine Learning for Healthcare  Conference <a href="https://youtu.be/5XyDZ8croZk">https://youtu.be/5XyDZ8croZk</a></li>
    </ul>
  </li>
  <li><strong>Nayan M</strong>, Salari M, Bozzo A, Ganglberger  W, Lu G, Carvalho F, Gusev A, Schneider A, Westover BM, Feldman AS. &ldquo;A machine  learning approach to predict progression on active surveillance for prostate  cancer&rdquo;. Urologic Oncology: Seminars and Original Investigations (in-press)  (2021). doi: 10.1016/j.urolonc.2021.08.007]
    <ul>
      <li>Article featured on UroToday.com <a href="https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/132403-a-machine-learning-approach-to-predict-progression-on-active-surveillance-for-prostate-cancer-beyond-the-abstract.html">https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/132403-a-machine-learning-approach-to-predict-progression-on-active-surveillance-for-prostate-cancer-beyond-the-abstract.html</a></li>
      <li>Article feature on Sperling Medical Group <a href="https://sperlingmedicalgroup.com/predicting-prostate-cancer-progression-during-active-surveillance/">https://sperlingmedicalgroup.com/predicting-prostate-cancer-progression-during-active-surveillance/</a></li>
    </ul>
  </li>
  <li>Garisto J, <strong>Nayan M,</strong> Fadaak K, Li K,  Pandya A, Leao R, Chung P, Shridar SS, Helou J, Kulkarni GS. &quot;Oncological  outcomes in the management of cT1-T2 cN0 penile squamous cell carcinoma.&quot;  Canadian Urological Association Journal 15.6 (2021). doi: 10.5489/cuaj.6762.</li>
  <li>Bobrowski A, <strong>Nayan M</strong>, Heimrath O, Goche  D, Ludzu E, Singal RK. &quot;Supply the demand: Assessment of the feasibility  of local non-urologists in relieving the burden of chronic indwelling catheters  in a low-income country.&quot; Canadian Urological Association Journal 15.5  (2021). doi: 10.5489/cuaj.6567.</li>
  <li><strong>Nayan M</strong>, Saarela O, Lawson K, Martin L,  Komisarenko M, Finelli A. Long-term outcomes after radical or partial nephrectomy  for T1a renal cell carcinoma: a population-based study. Canadian Urological Association  Journal. 2020 Jun 16. doi: 10.5489/cuaj.6343.</li>
  <li><strong>Nayan M</strong>, Jalali S, Kapoor A, Finelli A,  So A, Rendon R, Breau RH, Lavallee LT, Tanguay S, Heng D, Kawakami J, Basappa  NS, Bjarnason G, Pouliot F, Hamilton RJ. Diabetes and kidney cancer survival in  patients undergoing nephrectomy: a Canadian multi-center, propensity score analysis.  Urologic Oncology: Seminars and Original Investigations. 2019 Sep;37(9):576.e11-576.e16.  doi: 10.1016/j.urolonc.2019.06.006.</li>
  <li>Punjani N, <strong>Nayan  M,</strong> Jarvi K, Lo K, Lau S, Grober E. The Effect of Ethnicity on Semen Analysis  and Hormones in the Infertile Patient. Canadian Urological  Association Journal. 2019 Jul 23. doi: 10.5489/cuaj.5897.</li>
  <li>Hamilton RJ, <strong>Nayan M</strong>, Anson-Cartwright L, Atenafu EG, Bedard PL, Hansen A, Chung  P, Warde P, Sweet J, O&rsquo;Malley M, Sturgeon J, Jewett MAS. Treatment of Relapse  of Clinical Stage I Nonseminomatous Germ Cell Tumours on Surveillance. Journal  of Clinical Oncology. 2019 Feb 25:JCO1801250. doi: 10.1200/JCO.18.01250.</li>
  <li><strong>Nayan M</strong>,  Juurlink DN, Finelli A, Austin PC, Kulkarni GS, Uleryk E, Hamilton RJ. Metformin  Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis.  The American Journal of Clinical Oncology. 2019 Mar;42(3):275-284. doi: 10.1097/COC.0000000000000512.</li>
  <li>Lewin J, Dufort P, Halankar J, O&rsquo;Malley M,  Jewett MAS, Hamilton RJ, Gupta A, Lorenzo A, Traubici J, <strong>Nayan M</strong>, Leao R, Warde P, Chung P, Anson-Cartwright L, Sweet J, Hansen  AR, Metser U, Bedard PL. Applying radiomics to predict pathology of post  chemotherapy retroperitoneal nodal masses in germ cell tumors. Journal of Clinical  Oncology Clinical Cancer Informatics. 2018 May 11;(2):1-12. doi 10.1200/CCI.18.00004.</li>
  <li>Goldberg H, <strong>Nayan  M</strong>, Hamilton RJ. Conditional risk of relapse in patients with germ cell  testicular tumors: personalizing surveillance in clinical stage 1 disease. Current  Opinion in Urology. 2018;28(5):454-460. doi: 10.1097/MOU.0000000000000526.</li>
  <li><strong>Nayan M,</strong> Punjani N, Grober E, Lo K, Jarvi K. The use of assisted reproductive technology  before male factor infertility evaluation. Translational Andrology and Urology.  2018;7(4):678-685. doi: 10.21037/tau.2018.06.08.</li>
  <li>Jayalath VH, <strong>Nayan M</strong>, Finelli A, Komisarenko M, Timilshina N, Kulkarni GS, Fleshner  NE, Bhindi B, Evans A, Zlotta AR, Hamilton RJ. Statin use and time to progression  in men on active surveillance for prostate cancer. Prostate Cancer Prostatic  Dis. 2018 Jun 6. doi: 10.1038/s41391-018-0053-x.</li>
  <li>Richard PO, Ahmad AE, Bashir S, Zlotta A, Bhindi  B, Leao R, <strong>Nayan M</strong>, Mohammed A, Fleshner  NE, Kulkarni GS. Impact of oral hypoglycemic agents on mortality among diabetic  patients with non-muscle-invasive bladder cancer: A population-based analysis. Canadian  Urological Association Journal. 2018 Jun;12(6):203-210. doi: 10.5489/cuaj.4870.</li>
  <li>Leão R, <strong>Nayan  M,</strong> Punjani N, Fadaak K, Garisto J, Lewin J, Jewett MAS, Sweet J, Anson-Cartwright  L, Bedard PL, Chung P, Warde P, Power N, Winquist E. Hamilton RJ. A New Model  to Predict Benign Histology in Residual Retroperitoneal Masses After  Chemotherapy in Nonseminoma. European Urology Focus. 2018 Feb 7. pii: S2405-4569(18)30016-6.  doi: 10.1016/j.euf.2018.01.015. </li>
  <li><strong>Nayan M,</strong> Hamilton RJ. Dissecting the evolving risk of relapse over time in surveillance  for testicular cancer. Advances in Urology. 2018 Feb 19;2018:7182014. doi:  10.1155/2018/7182014.</li>
  <li><strong>Nayan M,</strong> Juurlink DN, Austin PC, McDonald EM, Finelli A, Kulkarni GS, Hamilton RJ. Medication Use and Kidney Cancer Survival: A Population-Based Study. International  Journal of Cancer. 2018 May 1;142(9):1776-1785. doi: 10.1002/ijc.31204.
    <ul>
      <li>Headline       article of American Urological Association Daily Scope on December 14th,       2017</li>
      <li>Article       featured on Cancer Therapy Advisor &ldquo;Non-steroidal Anti-inflammatory Drugs       May Improve Survival in Kidney Cancer&rdquo; <a href="http://www.cancertherapyadvisor.com/renal-cell-carcinoma/rcc-cancer-non-steroid-anti-inflammation-drugs-improve-survival/article/718212/">http://www.cancertherapyadvisor.com/renal-cell-carcinoma/rcc-cancer-non-steroid-anti-inflammation-drugs-improve-survival/article/718212/</a></li>
    </ul>
  </li>
  <li><strong>Nayan M,</strong> Juurlink DN, Austin PC, McDonald EM, Finelli A, Kulkarni GS, Hamilton RJ.  Medication Use and Kidney Cancer Risk: A Population-Based Study. European Journal  of Cancer. 2017 Sep;83:203-210. doi: 10.1016/j.ejca.2017.07.001.</li>
  <li><strong>Nayan M,</strong> Hamilton RJ, Juurlink DN, Finelli A, Kulkarni GS, Austin PC. A Critical  Appraisal of the Application of Propensity Score Methods in the Urology Literature.  British Journal of Urology International. 2017 Dec;120(6):873-880. doi:  10.1111/bju.13930.</li>
  <li>Bhindi B, Wallis CJD, <strong>Nayan M,</strong> Farrell AM, Trost LW, Hamilton RJ, Kulkarni GS, Finelli A,  Fleshner NE, Boorjian SA, Karnes RJ. The Association Between Vasectomy and  Prostate Cancer: A Systematic Review and Meta-analysis JAMA Internal Medicine. 2017  Sep 1;177(9):1273-1286. doi: 10.1001/jamainternmed.2017.2791</li>
  <li>Goldenberg MG, Skeldon SC,<strong> Nayan M,</strong> Suppiah Y, Chow L, Fryml E, Greenberg D, Singal R,  Goldenberg SL. Prostate-Specific Antigen Testing for Prostate Cancer Screening:  A National Survey of Canadian Primary Care Physicians&rsquo; Opinions and Practices  in 2016. Canadian Urological Association Journal. 2017 Dec;11(12):396-403. doi: 10.5489/cuaj.4486.</li>
  <li><strong>Nayan M,</strong> Finelli A, Jewett M, Juurlink DN, Austin PC, Kulkarni GS, Hamilton RJ. The Value  of Complementing Administrative Data with Abstracted Information on Smoking and  Obesity: A Study in Kidney Cancer. Canadian Urological Association Journal. 2017  Jun;11(6):167-171. doi: 10.5489/cuaj.4569.</li>
  <li><strong>Nayan M,</strong> Finelli A, Jewett M, Juurlink DN, Austin PC, Kulkarni GS, Hamilton RJ. Diabetes  and Kidney Cancer Outcomes: A Propensity Score Analysis. Endocrine.  2017 Feb;55(2):470-477. doi: 10.1007/s12020-016-1149-5.</li>
  <li><strong>Nayan M,</strong> Punjani N, Juurlink DN, Finelli  A, Austin PC, Kulkarni GS, Hamilton RJ. Statin Use and Kidney Cancer Survival  Outcomes: A Systematic Review and Meta-Analysis. Cancer Treat Reviews. 2016 Nov  27;52:105-116. doi: 10.1016/j.ctrv.2016.11.009.
    <ul>
      <li>Headline       article of American Urological Association Daily Scope on December 20th,       2016</li>
      <li>Article       featured on Cancer Therapy Advisor &ldquo;Kidney Cancer: Statin Use May Improve       Disease-specific Survival&rdquo; <a href="http://www.cancertherapyadvisor.com/renal-cell-carcinoma/kidney-cancer-statin-use-improve-disease-specific-survival/article/579952/">http://www.cancertherapyadvisor.com/renal-cell-carcinoma/kidney-cancer-statin-use-improve-disease-specific-survival/article/579952/</a></li>
      <li>Article       featured on Kidney Cancer Support Network &ldquo;Statins use may improve survival       in kidney cancer patients&rdquo; <a href="http://www.kcsn.org.uk/statin-use-may-improve-survival-kidney-cancer-patients/">http://www.kcsn.org.uk/statin-use-may-improve-survival-kidney-cancer-patients/</a></li>
    </ul>
  </li>
  <li><strong>Nayan M</strong>, Hamilton RJ, Macdonald E, Li  Q, Mamdani MM, Earle C, Kulkarni GS, Javi K, Juurlink DN. Vasectomy and  Prostate Cancer Risk: A Population-Based Matched Cohort Study. BMJ. 2016 Nov  3;355:i5546. doi: 10.1136/bmj.i5546. 
    <ul>
      <li>Article       featured on Reuters &ldquo;Vasectomies not linked to higher prostate cancer risk&rdquo; <a href="http://www.reuters.com/article/us-health-vasectomy-prostate-cancer-idUSKBN1352MY">http://www.reuters.com/article/us-health-vasectomy-prostate-cancer-idUSKBN1352MY</a></li>
      <li>Article       featured on New England Journal of Medicine Journal Watch &ldquo;No Association       Between Vasectomy and Prostate Cancer&rdquo; <a href="http://www.jwatch.org/na42778/2016/12/06/no-association-between-vasectomy-and-prostate-cancer">http://www.jwatch.org/na42778/2016/12/06/no-association-between-vasectomy-and-prostate-cancer</a></li>
      <li>Article       featured on Clinical Advisor &ldquo;Is vasectomy linked to risk of prostate cancer?&rdquo; <a href="http://www.clinicaladvisor.com/mens-health-information-center/vasectomy-has-no-association-with-prostate-cancer/article/574869/">http://www.clinicaladvisor.com/mens-health-information-center/vasectomy-has-no-association-with-prostate-cancer/article/574869/</a></li>
      <li>Article       featured on Ontario Institute for Cancer Research News &ldquo;Researchers       disprove link between vasectomies and prostate cancer using Ontario health       data&rdquo; <a href="https://news.oicr.on.ca/2017/01/researchers-disprove-link-between-vasectomies-and-prostate-cancer-using-ontario-health-data/">https://news.oicr.on.ca/2017/01/researchers-disprove-link-between-vasectomies-and-prostate-cancer-using-ontario-health-data/</a></li>
    </ul>
  </li>
  <li><strong>Nayan M</strong>,  Jewett M, Hosni A, Anson-Cartwright L, Bedard P, Moore M, Hansen AR, Chung P,  Warde P, Sweet J, O'Malley M, Hamilton RJ. Conditional Risk of Relapse on  Surveillance for Clinical Stage I Testicular Cancer. European Urology. 2017  Jan;71(1):120-127. doi: 10.1016/j.eururo.2016.07.013.</li>
  <li><strong>Nayan M,</strong> Macdonald EM, Juurlink DN, Austin PC, Finelli A, Kulkarni GS, Hamilton RJ.  Medication Use and Survival in Diabetic Patients with Kidney Cancer. Pharmacological  Research. 2016 Nov;113(Pt A):468-474. doi: 10.1016/j.phrs.2016.09.027.</li>
  <li><strong>Nayan M,</strong> Finelli A, Jewett M, Juurlink DN, Austin PC, Kulkarni GS, Hamilton RJ.  Metformin Use and Kidney Cancer Outcomes in Diabetics: A Propensity Score Analysis.  Clinical Genitourinary Cancer. 2016 Jun 23. pii: S1558-7673(16)30159-8. doi: 10.1016/j.clgc.2016.06.008.</li>
  <li><strong>Nayan M,</strong> Finelli A, Jewett M, Juurlink DN, Austin PC, Kulkarni GS, Hamilton RJ. Statin  Use and Kidney Cancer Outcomes: A Propensity Score Analysis. <a name="_Hlk10797799">Urologic Oncology: Seminars and Original Investigations</a>.  2016 Nov;34(11):487.e1-487.e6. doi: 10.1016/j.urolonc.2016.06.007.</li>
  <li><strong>Nayan M</strong>,  Jewett M, Anson-Cartwright L, Bedard P, Moore M, Chung P, Warde P, Sweet J,  O'Malley M, Hamilton RJ. Institution at Orchiectomy and Progression on Active  Surveillance for Clinical Stage 1 Non-Seminomatous Germ Cell Tumours. Canadian  Urological Association Journal. 10.5-6 (2016): 204-9. doi: 10.5489/cuaj.3513.</li>
  <li>Hosni A, Warde P, Jewett M, Bedard P, Hamilton  R, Moore M, <strong>Nayan M</strong>, Huang R,  Atenafu EG, O&rsquo;Malley M, Sweet J, Chung P. Clinical Characteristics and Outcomes  of Late Relapse in Stage I Testicular Seminoma Clinical Oncology (R Coll Radiol).  2016 Oct;28(10):648-54. doi: 10.1016/j.clon.2016.06.001.</li>
  <li><strong>Nayan M</strong>,  Bhindi B, Yu JL, Mamdani M, Sridhar S, Hermanns T, Hamilton RJ, Finelli A,  Jewett M, Zlotta A, Fleshner N, Kulkarni G. The Initiation of a Multi-Disciplinary  Bladder Cancer Clinic and the Uptake of Neoadjuvant Chemotherapy: A Time-Series  Analysis. Canadian Urological Association Journal. 2016 Jan-Feb;10(1-2):25-30.  doi: 10.5489/cuaj.3315.</li>
  <li><strong>Nayan M,</strong> Richard P, Jewett MAS, Kachura JR, Evans A, Hamilton RJ, Finelli A. Hematologic  parameters and small renal mass biopsy pathology. Clinical Genitourinary  Cancer. 2015 Dec 17. pii: S1558-7673(15)00337-7. doi: 10.1016/j.clgc.2015.12.007.</li>
  <li><strong>Nayan M, </strong>Jayalath  VH, Jewett MA, Bedard PL, Hamilton RJ. Randomized Controlled Trials in Testicular  Cancer: A Demographic and Quality Assessment. Urologic Oncology: Seminars and  Original Investigations. 2016 Feb;34(2):60.e7-60.e13. doi: 10.1016/j.urolonc.2015.09.007.</li>
  <li><strong>Nayan M</strong>,  Bhindi B, Yu JL, Hermanns T, Hamilton RJ, Finelli A, Jewett M, Zlotta A,  Fleshner N, Kulkarni G. The Effect of Metformin on Cancer-Specific Survival  Outcomes in Diabetic Patients Undergoing Radical Cystectomy For Urothelial Carcinoma  of the Bladder. Urologic Oncology: Seminars and Original Investigations. 2015  Sep;33(9):386.e7-386.e13. doi: 10.1016/j.urolonc.2015.05.024.</li>
  <li><strong>Nayan M</strong>,  Anson-Cartwright L, Jewett M, Sweet J, Bedard P, Moore M, Chung P, Warde P,  Hamilton RJ. Lymph Node Counts in Primary Retroperitoneal Dissection for Nonseminomatous  Germ Cell Tumours. Journal of Urology. 2015 Aug;194(2):386-91. doi:  10.1016/j.juro.2015.03.100.</li>
  <li>Russell CM, Espiritu PN, Kassouf W, Schwaab T, Buethe  DD, Dhilon J, Sexton WJ,  Poch M, Powsang  JM, Tanguay S, <strong>Nayan M</strong>, Alsaadi H,  Hanzly MI, Spiess PE. Surgical Outcomes in the Management of Isolated Nodal  Recurrences: A Multicenter International Retrospective Cohort. Journal of  Urology. 2014;192(2):350-6. doi: 10.1016/j.juro.2014.02.010.</li>
  <li><strong>Nayan M</strong>,  Houle AM, McDougall E, Fried G, and Andonian S. Establishing Milestones for  Urology Training: A Survey of the Canadian Academy of Urological Surgeons. Canadian  Urological Association Journal. 2012;6(1):30-3. doi: 10.5489/cuaj.11248.</li>
  <li><strong>Nayan M</strong>,  Elkoushy M, and Andonian S. Variations Between Two 24-hour Urine Collections in  Patients Presenting to a Tertiary Stone Clinic. Canadian Urological Association  Journal. 2012;6(1):30-3. doi: 10.5489/cuaj.11131.</li>
  <li>Paul A, <strong>Nayan  M</strong>, Khan A, Shum-Tim D, and Prakash S. Angiopoietin-1 Expressing Adipose  Stem Cells Genetically Modified with Baculovirus Nanocomplex: Investigation in  Rat Heart with Acute Infarction. International Journal of Nanomedicine.  2012;7:663-682. doi: 10.2147/IJN.S26882.</li>
  <li><strong>Nayan M</strong>,  Paul A, Chen G, Chiu RC, Prakash S, Shum-Tim D. Superior Therapeutic Potential of  Young Bone Marrow Mesenchymal Stem Cells by Direct Intramyocardial Delivery in  Aged Recipients with Acute Myocardial Infarction: In Vitro and In Vivo Investigation.  Journal of Tissue Engineering. 2011;2011:741213. doi: 10.4061/2011/741213.</li>
  <li>Chen G, <strong>Nayan  M</strong>, Duong M, Asenjo JF, Ge Y, Chiu RC, Shum-Tim D. Marrow stromal cells for  cell-based therapy: the role of antiinflammatory cytokines in cellular cardiomyoplasty.  Annals of Thoracic Surgery. 2010 Jul;90(1):190-7. doi: 10.1016/j.athoracsur.2010.02.074.</li>
</ol>
<p>&nbsp;</p>
<h2>Editorials</h2>
<ol>
  <li><strong>Nayan  M</strong>, Hamilton RJ, Juurlink DN, Austin P, Jarvi KA. Reply from Authors RE: Circumcision  and risk of HIV among males from Ontario, Canada. J Urol. 2021 Sep  23;101097JU0000000000002234. doi: 10.1097/JU.0000000000002234.</li>
  <li><strong>Nayan  M</strong>, Fleshner NE, Bozzo A. RE: Radiomics Features Measured with Multiparametric  Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness. Journal of  Urology. 2019 Sep;202(3):504-505. doi: 10.1097/01.JU.0000558548.34484.39.</li>
  <li><strong>Nayan M</strong>. CUA-AUA International Fellows  Program: San Francisco 2018. Canadian Urological Association Journal. 2018  Aug;12(8):227-228. doi: 10.5489/cuaj.5500.</li>
  <li><strong>Nayan M,</strong> Jewett MAS, Finelli A. Uncoupling  diagnosis and treatment of incidentally imaged renal masses. JAMA Intern Med. 2018  May 1;178(5):727-728. doi: 10.1001/jamainternmed.2018.1180. </li>
  <li><strong>Nayan M,</strong> Juurlink DN, Finelli A, Kulkarni  GS, Hamilton RJ. Challenges Interpreting Chemoprevention Studies Using  Observational Data. Journal of Clinical Oncology. 2017 Dec 20:JCO2017761064. doi:  10.1200/JCO.2017.76.1064.</li>
  <li><strong>Nayan M</strong>, Hamilton RJ. Reply from Authors  re: Peter Albers. Surveillance of Patients with Clinical Stage I Testis Cancer  is Safe and Will Remain Unchanged. Eur Urol 2017;71:130-131. European Urology. 2017  Jan;71(1):131-132. doi: 10.1016/j.eururo.2016.11.004.</li>
</ol>
<p>&nbsp;</p>
<h2>Book Chapters</h2>
<ol>
  <li><strong>Nayan M</strong>,  Nouraeyen N, Chiu W, and Shum-Tim D. Chapter 4 - Aging and Stem Cell Therapy: A  Review and Highlights of Current Controversies. Stem Cell Bioengineering and Tissue  Engineering Microenvironments; World Scientific Publishing Company, ISBN  978-981-283-788-2, 2011</li>
</ol>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
</body>
</div>	
	
</html>
